References
- Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78: 257–61.
- Padma-Nathan H. A new era in the treatment of erectile dysfunction. Am J Cardiol 1999; 84(5B): 18N–23N.
- Shabsigh R, Padma-Nathan H, Gittleman M, et al. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 2000; 55; 477–80.
- Hatzichristou DG, Apostolidis A, Tzortzis V, et al. Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year. J Urol 2000; 164: 1197–200.
- Kim SC, Chang IH, Jeon HJ. Preference for oral sildenafil or intracavernosal injection in patients with erectile dysfunction already using intracavernosal injection for > 1 year. BJU Int 2003; 92(3): 277–80.
- Nehra A. Intracavernosal therapy: when oral agents fail. Curr Urol Rep 2001; 2(6): 468–72.
- Lue T, Goldstein I, Traish A. Comparison of oral and intracavernosal vasoactive agents in penile erection. Int J Impot Res 2000; 12 Suppl 1:S81–8.
- Virag R, Shoukry K, Floresco J, Nollet F, Greco E. Intracaverous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. J Urol 1991; 145: 287–293.
- Von Heyden B, Donatucci CF, Kaula N, Lue TF. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. J of Urol 1993; 149: 1288–90.
- Fabbri A, Aversa A, Isidori A. Erectile dysfunction: an overview. Hum Reprod Update 1997: 3(5): 455–66.
- Sagori PR, Teloken C, Souto CA. Atropine role in the pharmacological erection test: study of 228 patients. J Urol 1997; 158(5): 1760–3.
- Weiss JN, Ravalli R, Badlani GH. Intracavernous pharmacotherapy in psychogenic impotence. Urol 1991; 37(5): 441–3.
- Earle CM, Keogh EJ, Ker JK, Cherry DJ, Tulloch AGS, Lord DJ. The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury. Paraplegia 1992; 30: 273–6.
- Montorsi F, Guazzoni G, Bergamashi F, et al. Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence. Acta Diabetol 1994; 31(1): 1–5.
- Bestane WJ, Bestane MC, Ramos NA. Prospective study of sodium nitroprusside in pharmacologically induced erection. Braz J Urol 2001; 27: 155–8.
- Shamloul R, El-Dakhly M, Ghanem H, Gadallah A, Mokhtar H. Intracaverous chlorpromazine versus phentolamine: a double-blind clinical comparative study. J Sex Med 2004;1(3):310–3.
- Uebel RA, Wium CA, Schmidt AC. Stability evaluation of a prostaglandin E1 saline solution packed in insulin syringes. Int J Imp Res 2001; 13: 16–7.
- Soli M, Bertaccini A, Carparelli F, et al. Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. J Urol 1998; 160(2): 551–8.
- Lawrence AT, Yanping Z. Long-term stability of trimix: a three-drug injection used to treat erectile dysfunction. IJPC 2004; 8(3): 231–5.